These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 33818053)

  • 1. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
    Allison K; Patel DG; Greene L
    JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020.
    Berkowitz ST; Groth SL; Gangaputra S; Patel S
    JAMA Ophthalmol; 2021 Jun; 139(6):629-637. PubMed ID: 33885724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
    Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
    JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.
    Tahhan AS; Vaduganathan M; Greene SJ; Alrohaibani A; Raad M; Gafeer M; Mehran R; Fonarow GC; Douglas PS; Bhatt DL; Butler J
    JAMA Cardiol; 2020 Jun; 5(6):714-722. PubMed ID: 32211813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
    Mattei LH; Robb L; Banning K; Polan RM; Cote ML
    Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
    Huamani KF; Metch B; Broder G; Andrasik M
    Public Health Rep; 2019; 134(1):72-80. PubMed ID: 30517057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.
    Reddy KP; Faggioni M; Eberly LA; Halaby R; Sanghavi M; Lewey J; Mehran R; Coylewright M; Herrmann HC; Giri J; Fanaroff AC; Nathan AS
    JAMA Cardiol; 2023 Sep; 8(9):871-878. PubMed ID: 37494015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
    Lolic M; Araojo R; Okeke M; Temple R
    J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National enrollment of lung cancer clinical trials is disproportionate based on race and health care access.
    Kwak M; Bassiri A; Jiang B; Sinopoli J; Tapias-Vargas L; Linden PA; Towe CW
    J Thorac Cardiovasc Surg; 2024 Oct; 168(4):1235-1242. PubMed ID: 38123063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
    Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
    JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic underrepresentation in dermatology clinical trials.
    Mineroff J; Nguyen JK; Jagdeo J
    J Am Acad Dermatol; 2023 Aug; 89(2):293-300. PubMed ID: 37062462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
    Nemala A; Ullah A; Yacur M; Karim NA
    Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
    Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
    JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies.
    Morin SF; Sengupta S; Cozen M; Richards TA; Shriver MD; Palacio H; Kahn JG
    Public Health Rep; 2002; 117(3):263-72; discussion 231-2. PubMed ID: 12432137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation and Comparison of Current and Future Racial/Ethnic Representation in the US Health Care Workforce.
    Salsberg E; Richwine C; Westergaard S; Portela Martinez M; Oyeyemi T; Vichare A; Chen CP
    JAMA Netw Open; 2021 Mar; 4(3):e213789. PubMed ID: 33787910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.
    Khan MS; Shahid I; Siddiqi TJ; Khan SU; Warraich HJ; Greene SJ; Butler J; Michos ED
    J Am Heart Assoc; 2020 Jun; 9(11):e015594. PubMed ID: 32427023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.